Alja Zottel
Maribor, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Conserved miRNA regulators of PD-1/PD-L1 in glioblastoma and colorectal cancer.
Journal: RNA biology
Published: August 19, 2026
Editorial: Cell models and preclinical validation of immune-mediating biological therapies.
Journal: Frontiers in immunology
Published: June 11, 2026
AKR1C inhibitors medroxyprogesterone acetate and mefenamic acid exhibit antitumor activity alone and combined with carboplatin in platinum-resistant high-grade serous ovarian cancer models.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 24, 2025
In silico analysis reveals distinct changes in markers of epithelial to mesenchymal transition in glioma subtypes.
Journal: Biomolecules & biomedicine
Published: April 29, 2025
The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression.
Journal: Neuro-oncology advances
Published: February 18, 2025
In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.
Journal: Antibodies (Basel, Switzerland)
Published: December 11, 2024
TNFSF14 and CD44 are overexpressed in glioblastoma and associated with immunosuppressive microenvironment.
Journal: Biomolecules & biomedicine
Published: December 03, 2024
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies.
Journal: Frontiers in immunology
Published: September 12, 2024
Cytotoxic effect of 13α-estrane derivatives on breast, endometrial and ovarian cancer cell lines.
Journal: The Journal of steroid biochemistry and molecular biology
Published: March 01, 2023
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.
Journal: Cancers
Published: December 07, 2022
Last Updated: 09/26/2026